Xeris Pharmaceuticals | XERS - Nettoeinkommen

Aktienkurs
6.01
Täglich Wechseln
-0.08 -1.31%
Monatlich
7.32%
Jährlich
31.51%
Q2 Prognose
5.92




Nettoeinkommen Veränderung Datum
Celltrion KRW 331.35B 270.18B 2025-09
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pharma Mar EUR 59.66M 63.76M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 687.04M 244.51M 2025-09